Muse, Victorine P.
Placido, Davide
Haue, Amalie D.
Brunak, Søren
Funding for this research was provided by:
Novo Nordisk Fonden (NNF14CC0001, NNF14CC0001, NNF14CC0001, NNF14CC0001)
Innovationsfonden (5184-00102B, 5184-00102B)
Copenhagen University
Article History
Received: 28 March 2023
Accepted: 26 February 2024
First Online: 4 March 2024
Declarations
:
: The need for informed consent was waived by the Danish Patient Safety Authority (3–3013-1731 and 3– 3013–1723). The study was approved as a registry study where consent and ethical approval is not needed by Danish law. All studies were carried out in accordance with relevant guidelines and regulations; please see the data access approval section for further approval information.
: Not Applicable.
: SB reports ownerships in Intomics A/S, Hoba Therapeutics Aps, Novo Nordisk A/S, Lundbeck A/S, ALK abello A/S and managing board memberships in Proscion A/S and Intomics A/S. All other authors of this manuscript have no conflicts of interests (financial or non-financial) to disclose.